At GW Pharmaceuticals, we remain committed to ensuring our patients, healthcare partners and employees are supported during these challenging times. We are actively monitoring our supply chain and taking steps to help ensure continued supply of our products to patients. We will continue to monitor the COVID-19 situation and take steps to ensure the access and assistance for patients and healthcare partners remain consistent.
If you wish to discuss more specific details please contact GW Pharmaceuticals via phone on +44 (0) 1223 238170 or via email at firstname.lastname@example.org . If you are reporting an Adverse Event and/or a Product Complaint, and you receive a network busy signal (i.e if all lines are busy or engaged) please continue to try your call throughout the day or, preferably report via the above email address.